Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products
November 08, 2021 08:00 ET
|
Levitee Labs Inc.
Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, CanadaNew pharmacy to focus on production of intranasal ketamine and sublingual preparations, topical and...
Levitee Labs Announces Gold Sponsorship of Wonderland Psychedelic Conference in Miami
November 05, 2021 08:00 ET
|
Levitee Labs Inc.
Levitee Labs will be a Gold Sponsor and VIP Lounge Sponsor at the world’s largest psychedelic medicine conference If you would like to attend either of Levitee’s private events, you can register at...
Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services
October 28, 2021 08:00 ET
|
Levitee Labs Inc.
Levitee Labs has acquired its first five addiction clinics, three specialized pharmacies and pioneering technology company that cumulatively treat tens of thousands of Canadian patients with substance...
Levitee Labs Enters into Credit Facility For Up To $12 Million
October 21, 2021 08:00 ET
|
Levitee Labs Inc.
VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) (FSE: 7H7) (the "Company" or "Levitee”), an integrative wellness company with a...
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
October 18, 2021 08:30 ET
|
Levitee Labs Inc.
VANCOUVER, British Columbia, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) an integrative wellness company with a...
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada
October 14, 2021 08:45 ET
|
Levitee Labs Inc.
Dr. Mosli has over a decade of healthcare experience specializing in addiction, leading innovation in reorienting health systems, and increasing health equalityDr. Mosli spent the last five years as a...
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy
October 12, 2021 08:45 ET
|
Levitee Labs Inc.
Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x TTM EBITDA of $180,000Levitee Labs to use compounding capabilities to build its...
Levitee Labs Publishes First Revenue Figures for August 2021
October 05, 2021 10:29 ET
|
Levitee Labs Inc.
Levitee Labs achieves August 2021 revenues of $893,863Levitee Clinics & Pharmacies achieves August 2021 revenues of $543,705Continued growth across core divisions of the company, including Levitee...
Levitee Labs Announces Listing On Frankfurt Stock Exchange
October 01, 2021 11:25 ET
|
Levitee Labs Inc.
VANCOUVER, British Columbia, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT); (OTCPK: LVTTF); (FSE: 7H7), an integrative wellness company with a...
Levitee Labs Announces DTC Eligibility Approval
September 24, 2021 08:45 ET
|
Levitee Labs Inc.
VANCOUVER, British Columbia, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT) (OTCPK: LVTTF), an integrative wellness company with a diversified...